Status:
COMPLETED
Acupuncture in Herpes Zoster Neuralgia (ACUZoster)
Lead Sponsor:
Dominik Irnich
Conditions:
Herpes Zoster
Postherpetic Neuralgia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Symptoms that herald herpes zoster include pruritus, dysesthesia and pain along the distribution of the involved dermatome. The most distressing symptom is typically pain and the most feared complicat...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of acute HZ
- Pain intensity \> 30 mm visual analog scale
Exclusion
- Patients with insulin-dependent diabetes mellitus or other diseases influencing the peripheral sensibility (e.g., polyneuropathia, chronic pain syndromes, cutaneous irritations i.e. burns)
- Patients under age
- Uncompliance
- Pregnancy or lactation
- Surgery within the last 3 month
- Severe heart/lung/kidney disease
- Diseases influencing the quality of life
- Psychiatric diseases (e.g., depression, schizophrenia, dementia)
- Chronic intake of analgesics, neuroleptics, antidepressants, corticoids, alpha-agonists
- Acupuncture, transdermal electric neurostimulation or other Complementary and Alternative Medicine treatment within the last 4 weeks
- Contraindications according to the summary of product informations against analgesic treatment (i.e., metamizol, paracetamol, tramadol, morphine) or the investigational medicinal products (gabapentine, acupuncture needles)
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2018
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00885586
Start Date
November 1 2008
End Date
April 5 2018
Last Update
August 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multidisciplinary Pain Unit, University of Munich
Munich, Bavaria, Germany, 80336